Detalles de la búsqueda
1.
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity.
Mycoses
; 66(10): 854-868, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37431241
2.
Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).
J Clin Microbiol
; 60(4): e0244921, 2022 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35249367
3.
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections.
Med Mycol
; 60(5)2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35511210
4.
Evaluation of the Post-Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata.
Mycoses
; 65(11): 1040-1044, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35778886
5.
Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33431416
6.
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles.
Mycoses
; 64(10): 1279-1290, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33705591
7.
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071045
8.
Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015043
9.
Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32179519
10.
In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071042
11.
In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018.
Antimicrob Agents Chemother
; 63(11)2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427295
12.
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010862
13.
Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016.
Antimicrob Agents Chemother
; 63(1)2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373807
14.
Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres.
J Antimicrob Chemother
; 74(5): 1306-1310, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30753485
15.
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.
Antimicrob Agents Chemother
; 62(4)2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29378719
16.
Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from U.S. Medical Centers.
Antimicrob Agents Chemother
; 62(3)2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29263077
17.
In Vitro Activities of Ceftaroline and Comparators against Streptococcus pneumoniae Isolates from U.S. Hospitals: Results from Seven Years of the AWARE Surveillance Program (2010 to 2016).
Antimicrob Agents Chemother
; 62(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158271
18.
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061754
19.
In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30061288
20.
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.
J Antimicrob Chemother
; 73(10): 2748-2756, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29982565